CRVS
Corvus Pharmaceuticals, Inc.$14.86-0.12 (-0.77%)Prev Close$14.97·MCap$1.26B·P/E—·Vol603.5K·Yield—
▲
Buys (12M)
2
$333.7K
▼
Sells (12M)
0
$0.00
◆
Net Activity
Net Buyer
$333.7K
●
Active Insiders
2
last 12 mo
Over the past 12 months, insider activity at Corvus Pharmaceuticals, Inc. (CRVS) has been exclusively buying, with 2 insider purchases totaling $333.7K and 0 insider sales totaling $0.00. The most recent insider transaction was by Moore David Scott (director), who purchased $250.2K worth of shares on Jun 15, 2026. Corvus Pharmaceuticals, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $1.26B.
CRVS Insider Trading Activity
CRVS Insider Buying Activity
The following table shows recent insider purchases of Corvus Pharmaceuticals, Inc. (CRVS) stock reported via SEC Form 4 filings.
CRVS Insider Selling Activity
The following table shows recent insider sales of Corvus Pharmaceuticals, Inc. (CRVS) stock reported via SEC Form 4 filings.